spacer
home > white papers > Exploring Protein Stability by nanoDSF - NanoTemper Technologies GmbH
WHITE PAPERS
logo_NanoTemper.jpg

NanoTemper Technologies GmbH

phone +49 (0) 89 4522 8950
email stefan.duhr@nanotemper.de
web http://www.nanotemper-technologies.com
email Floessergasse 4, 81369 Munich

Exploring Protein Stability by nanoDSF

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
Exploring Protein Stability by nanoDSF
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

WuXi STA Forms Strategic Partnership with Coherent Biopharma

Shanghai, 1st December 2021: WuXi STA a subsidiary of WuXi AppTec and Coherent Biopharma, announced the signing of a strategic partnership agreement.
More info >>


White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement